Background: Irritable bowel syndrome (IBS) reduces patients' quality of life and causes great
burdens due to its unclear pathogenesis and criteria for diagnosis. This study aimed to …

Purpose The diagnosis of irritable bowel syndrome (IBS) is based on symptom-based
criteria due to lack of reliable disease-specific biomarkers. Gut microbiota is perturbed in IBS …

AIM: To investigate the correlations between self-reported symptoms of irritable bowel
syndrome (IBS) and the gastrointestinal (GI) microbiota composition. METHODS: Fecal …

Objective Irritable bowel syndrome (IBS) is a common gastrointestinal disorder that is difficult
to diagnose and treat due to its inherent heterogeneity and unclear aetiology. Although there …

The gut microbiota and its related metabolites differ between inflammatory bowel disease
(IBD) patients and healthy controls. In this study, we compared faecal volatile organic …

Background Irritable bowel syndrome (IBS) is a functional disorder commonly associated
with extra‐intestinal symptoms. However, the prevalence of these symptoms according to …

Summary Background Current subgrouping of Irritable Bowel Syndrome (IBS) is exclusively
based on stool consistency without considering other relevant gastrointestinal (GI) …

Fecal microbial community could not fully represent the intestinal microbial community.
However, most studies analyzing diarrhea-dominant irritable bowel syndrome (IBS-D) were …

Background and aims Irritable bowel syndrome (IBS) is a common functional gastrointestinal
disorder that may be triggered by enteric pathogens and has also been linked to alterations …

Background The potential of the fecal metabolome to serve as a biomarker for irritable bowel
syndrome (IBS) depends on its stability over time. Therefore, this study aimed to determine …